RIME Fundamental Analysis - ALGORHYTHM HOLDINGS INC

Fundamental Rating

Overall RIME gets a fundamental rating of 1 out of 10. We evaluated RIME against 60 industry peers in the Household Durables industry. RIME may be in some trouble as it scores bad on both profitability and health. RIME does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

RIME had negative earnings in the past year.

RIME had a negative operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: RIME reported negative net income in multiple years.

The reported operating cash flow has been mixed in the past 5 years: RIME reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -264.67%, RIME is not doing good in the industry: 96.67% of the companies in the same industry are doing better.

With a Return On Equity value of -1935.47%, RIME is not doing good in the industry: 95.00% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-264.67%
ROE	-1935.47%
ROIC	N/A

ROA(3y)-51.31%

ROA(5y)-31.64%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 18.56%, RIME is doing worse than 80.00% of the companies in the same industry.

In the last couple of years the Gross Margin of RIME has declined.

The Profit Margin and Operating Margin are not available for RIME so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	18.56%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-8.83%

GM growth 5Y-4.28%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

RIME does not have a ROIC to compare to the WACC, probably because it is not profitable.

RIME has less shares outstanding than it did 1 year ago.

The number of shares outstanding for RIME has been increased compared to 5 years ago.

RIME has a worse debt/assets ratio than last year.

2.2 Solvency

RIME has an Altman-Z score of -9.53. This is a bad value and indicates that RIME is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -9.53, RIME is not doing good in the industry: 95.00% of the companies in the same industry are doing better.

A Debt/Equity ratio of 2.86 is on the high side and indicates that RIME has dependencies on debt financing.

RIME has a worse Debt to Equity ratio (2.86) than 93.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	2.86
Debt/FCF	N/A
Altman-Z	-9.53

ROIC/WACCN/A

WACC20.92%

2.3 Liquidity

A Current Ratio of 0.53 indicates that RIME may have some problems paying its short term obligations.

With a Current ratio value of 0.53, RIME is not doing good in the industry: 96.67% of the companies in the same industry are doing better.

RIME has a Quick Ratio of 0.53. This is a bad value and indicates that RIME is not financially healthy enough and could expect problems in meeting its short term obligations.

RIME's Quick ratio of 0.53 is on the low side compared to the rest of the industry. RIME is outperformed by 73.33% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.53
Quick Ratio	0.53

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.34% over the past year.

Looking at the last year, RIME shows a very negative growth in Revenue. The Revenue has decreased by -44.67% in the last year.

RIME shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.76% yearly.

EPS 1Y (TTM)68.34%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-104.38%

Revenue 1Y (TTM)-44.67%

Revenue growth 3Y-19.95%

Revenue growth 5Y-12.76%

Sales Q2Q%-83.58%

3.2 Future

RIME is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -47.61% yearly.

RIME is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 2301.92% yearly.

EPS Next YN/A

EPS Next 2Y-47.61%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-86.17%

Revenue Next 2Y2301.92%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RIME. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as RIME's earnings are expected to decrease with -47.61% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-47.61%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for RIME!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

ALGORHYTHM HOLDINGS INC

NASDAQ:RIME (1/7/2026, 5:00:03 PM)

After market: 1.17 -0.05 (-4.1%)

1.22

0 (0%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryHousehold Durables

Earnings (Last)11-28 2025-11-28

Earnings (Next)04-14 2026-04-14

Inst Owners2.21%

Inst Owner Change0%

Ins Owners0.89%

Ins Owner Change0%

Market Cap3.32M

Revenue(TTM)14.46M

Net Income(TTM)-28.70M

Analysts82.86

Price Target5.1 (318.03%)

Short Float %7.93%

Short Ratio0.83

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.23
P/FCF	N/A
P/OCF	N/A
P/B	2.24
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-110.55

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-3.49

FCFYN/A

OCF(TTM)-3.29

OCFYN/A

SpS5.32

BVpS0.55

TBVpS-1.39

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-264.67%
ROE	-1935.47%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	18.56%
FCFM	N/A

ROA(3y)-51.31%

ROA(5y)-31.64%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-8.83%

GM growth 5Y-4.28%

F-Score3

Asset Turnover1.33

Health

		Industry Rank	Sector Rank
Debt/Equity	2.86
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	-874.6%
Cap/Sales	3.81%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.53
Quick Ratio	0.53
Altman-Z	-9.53

F-Score3

WACC20.92%

ROIC/WACCN/A

Cap/Depr(3y)61.29%

Cap/Depr(5y)88.63%

Cap/Sales(3y)0.39%

Cap/Sales(5y)0.59%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)68.34%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-104.38%

EPS Next YN/A

EPS Next 2Y-47.61%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-44.67%

Revenue growth 3Y-19.95%

Revenue growth 5Y-12.76%

Sales Q2Q%-83.58%

Revenue Next Year-86.17%

Revenue Next 2Y2301.92%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y24.45%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-47620%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-6068.67%

OCF growth 3YN/A

OCF growth 5YN/A

ALGORHYTHM HOLDINGS INC / RIME FAQ

Can you provide the ChartMill fundamental rating for ALGORHYTHM HOLDINGS INC?

ChartMill assigns a fundamental rating of 1 / 10 to RIME.

What is the valuation status for RIME stock?

ChartMill assigns a valuation rating of 0 / 10 to ALGORHYTHM HOLDINGS INC (RIME). This can be considered as Overvalued.

Can you provide the profitability details for ALGORHYTHM HOLDINGS INC?

ALGORHYTHM HOLDINGS INC (RIME) has a profitability rating of 1 / 10.

What is the financial health of ALGORHYTHM HOLDINGS INC (RIME) stock?

The financial health rating of ALGORHYTHM HOLDINGS INC (RIME) is 0 / 10.

ALGORHYTHM HOLDINGS INC (RIME) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ALGORHYTHM HOLDINGS INC / RIME FAQ

Can you provide the ChartMill fundamental rating for ALGORHYTHM HOLDINGS INC?

What is the valuation status for RIME stock?

Can you provide the profitability details for ALGORHYTHM HOLDINGS INC?

What is the financial health of ALGORHYTHM HOLDINGS INC (RIME) stock?